8111:TSEGoldwin Inc. Analysis
Data as of 2026-05-20 - not real-time
NT$61.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Ligitek Electronics is trading at TWD 61, which sits below its 20‑day (TWD 67.37) and 50‑day (TWD 66.23) simple moving averages and just under the 200‑day SMA (TWD 62.08), indicating short‑term weakness despite a nominally bullish trend direction. The RSI of 37.4 suggests the stock is approaching oversold territory, yet the MACD remains bearish with the line well under the signal, pointing to continued downside momentum. Valuation metrics are stark: a trailing PE of 160.5 versus an industry average of 38, and a DCF‑derived fair value of only TWD 20.06, imply the market is pricing the stock at a significant premium. Fundamentals are modest – revenue is flat (-0.5%), gross margin sits at 30% and operating margin under 5%, while ROE is a low 2.99% and the payout ratio exceeds 200%, raising concerns about dividend sustainability. The company holds ample cash (TWD 948 M) relative to debt (TWD 604 M), but high volatility (58% over 30 days) and a recent 25% max drawdown add to the risk profile. With support around TWD 60 and resistance near TWD 80.6, the near‑term price action will likely hinge on whether buyers can defend the support level amid these mixed technical and fundamental signals.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support at TWD 60
- Bearish MACD histogram indicating continued downside pressure
- High valuation gap between market price and DCF fair value
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- PE of 160.5 far exceeds industry average of 38
- Unsustainable dividend payout ratio over 200%
- Low profitability margins and modest ROE
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong cash position relative to debt
- Diversified product portfolio across LED, medical devices, and EV components
- Sector secular demand for electronic components despite current overvaluation
Key Metrics & Analysis
Financial Health
Revenue Growth-0.50%
Profit Margin4.82%
P/E Ratio160.5
ROE2.99%
ROA1.35%
Debt/Equity45.07
P/B Ratio5.0
Op. Cash FlowNT$177.9M
Free Cash FlowNT$142.5M
Industry P/E38.0
Technical Analysis
TrendBullish
RSI37.4
SupportNT$60.00
ResistanceNT$80.60
MA 20NT$67.37
MA 50NT$66.23
MA 200NT$62.08
MACDBearish
VolumeDecreasing
Fear & Greed Index89.34
Valuation
Fair ValueNT$20.06
GradeOvervalued
TypeValue
Dividend Yield1.35%
Risk Assessment
Beta0.65
Volatility58.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.